Transcat News Releases

ROCHESTER, NY, March 30, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and valueadded distributor of professional grade handheld test, measurement and control instrumentation, provided an update on its operations and actions to address the COVID-19 pandemic.

We understand that calibration may be an essential part of your supply chain. As an essential business, Transcat is here to offer you uninterrupted services through our network of calibration labs across North America.

Transcat Calibration Pick up & Delivery Service

FLIR Thermal Imagers FAQ for Elevated Body Temperature Screenings

March 19th, 2020 Update: Transcat’s Response to the Coronavirus Pandemic from President & CEO, Lee Rudow

Update Transcat's approach around the Coronavirus

We understand that there may be a desire to understand Transcat’s current approach around the Coronavirus, (COVID-19) across the United States, Canada, and other international customer locations.

Transcat's approach around the Coronavirus

LOS ANGELES, CA / ACCESSWIRE / February 26, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today announced that Michael J. Tschiderer, Chief Financial Officer, will present at the LD Micro Virtual Investor Conference on Tuesday, March 3, 2020.

Adds new Service capabilities, expands market penetration to the life sciences market and strengthens Distribution sales platform

ROCHESTER, NY, January 22, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its third quarter fiscal year 2020 results after the close of financial markets on Tuesday, February 4, 2020.

• Record third quarter consolidated revenue of $43.2 million in fiscal 2020
• Solid Service segment organic revenue growth of 7.8% reflects continued market expansion, including within the highly regulated life sciences market
• Distribution segment revenue growth of 3.5%
• Generated $8.2 million in cash from fiscal year-to-date operations, up 13.6%

ROCHESTER, NY, January 22, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its third quarter fiscal year 2020 results after the close of financial markets on Tuesday, February 4, 2020.

ROCHESTER, NY, October 28, 2019 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has appointed Oksana S. “Sandy” Dominach as an independent director to its Board. Ms. Dominach brings more than 32 years of experience and expertise in financial strategy, risk management and treasury, as well as over ten years of experience participating on a variety of public and non-for-profit boards. She is currently the Senior Vice President & Treasurer at Constellation Brands, Inc. (NYSE: STZ), a leading international producer and marketer of beer, wine and spirits.